PMI.US Picard Medical, Inc.
- Market cap
- USD 17.0M
- P/E
- 3.1x
- P/B
- 10.37x
- ROE
- -1,553.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is PMI.US undervalued?
Graham numberPMI.US trades 19.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Picard Medical, Inc. fundamental analysis
No fundamental analysis for Picard Medical, Inc. yet.
Picard Medical, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Ariz…
Full company profilePicard Medical, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Picard Medical, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 4.11M | 5.04M | 4.39M | 4.94M | 5.76M |
| Gross Profit | -4.99M | -2.31M | -112K | 200K | 1.31M |
| Operating Income | -11.1M | -15.5M | -13.7M | -12.8M | -15.0M |
| EBITDA | -10.6M | -14.8M | -17.5M | -26.5M | -18.8M |
| Net Income | -11.2M | -15.6M | -21.1M | -27.0M | -20.7M |
| EPS | -7.75 | -11 | -15 | -18 | -8.82 |
| Balance Sheet | |||||
| Total Assets | 15.4M | 11.4M | 12.1M | 22.5M | 9.06M |
| Total Liabilities | 4.07M | 14.9M | 35.8M | 18.8M | 7.73M |
| Shareholders' Equity | 11.4M | -3.55M | -23.7M | 3.79M | 1.33M |
| Cash & Short-term Investments | 152K | 244K | 96.0K | 7.45M | 67.0K |
| Total Debt | 1.96M | 9.41M | 20.9M | 6.98M | 1.49M |
| Cash Flow | |||||
| Operating Cash Flow | -10.7M | -10.6M | -11.9M | -15.7M | -9.53M |
| Capital Expenditure | 29.0K | 7.00K | 0.00 | 0.00 | 34.7K |
| Free Cash Flow | -10.8M | -10.6M | -11.9M | -15.7M | -9.57M |
| Ratios | |||||
| ROE | -98.2% | - | - | -712.6% | -1,553.4% |
| ROA | -72.3% | -136.9% | -173.9% | -119.7% | -227.9% |
| Net Profit Margin | -271.5% | -308.7% | -479.5% | -546.6% | -358.6% |
| Debt to Equity | 0.17x | - | - | 1.84x | 1.12x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Picard Medical, Inc. dividends
Picard Medical, Inc. has not paid dividends in the last 4 fiscal years.
Last stock split: 1:50 on Aug 3, 2026.
Who owns Picard Medical, Inc.
- Insiders 39.82%
- Institutions 4.76%
- Public & others 55.42%
- Shares outstanding 2.46M
- Free float 1.28M
Picard Medical, Inc. company profile
- Company name
- Picard Medical, Inc.
- Ticker
- PMI.US
- Exchange
- USA Stocks
- Listed since
- Aug 29, 2025
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 75
- Fiscal year end
- December
- Address
- 1992 East Silverlake Road, Tucson, AZ, United States, 85713
- Phone
- 520 545 1234
- Website
- picardmedical.com
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc. management
4- Dr. Yuncai Fang Ph.D.CEO & Chairman of the Board · born 1966
- Mr. Matthew SchusterChief Operating Officer · born 1981
- Ms. Georgina SmithChief Accounting Officer · born 1972
- Dr. Frank Tinker Ph.D.Chief Technology Officer of SynCardia Systems, LLC · born 1956